MedPath

CRITITECH, INC.

CRITITECH, INC. logo
🇺🇸United States
Ownership
Holding
Established
2001-01-01
Employees
11
Market Cap
-
Website
http://www.crititech.com

Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers

Phase 1
Completed
Conditions
Peritoneal Neoplasms
Interventions
First Posted Date
2008-04-25
Last Posted Date
2014-02-27
Lead Sponsor
CritiTech, Inc.
Target Recruit Count
22
Registration Number
NCT00666991
Locations
🇺🇸

Cancer Center of Kansas, Wichita, Kansas, United States

🇺🇸

Peggy and Charles Stephenson Oklahoma Cancer Center, Oklahoma City, Oklahoma, United States

🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath